Adverse Cases
- Codeine use in children after tonsillectomy and/or adenoidectomy
- Methoxyflurane and occupational exposure
- Quetiapine and QT prolongation
- bioCSL Fluvax - not for children under 5 years
- Pioglitazone risk-benefit review
- 5-alpha reductase inhibitors and risk of high-grade prostate cancer
- Duloxetine and serotonin syndrome
- Minocycline and intracranial hypertension
- Atomoxetine and suicidality in children and adolescents
- Rotavirus vaccination and the risk of intussusception
- Drug-induced liver injury
- Vancomycin and nephrotoxicity
- Dapagliflozin - new chemical entity
- Dexmedetomidine hydrochloride and cardiovascular events
- Bevacizumab and necrotising fasciitis
- Anticholinergics and cognitive impairment
- Changes to cough and cold medicines for use in children
- Update - Progressive multifocal leukoencephalopathy (PML)
- Mitigating risks of dabigatran: right patient, right dose and careful clinical monitoring
- New dabigatran contraindication
- Montelukast - neuropsychiatric risks
- Denosumab and severe hypocalcaemia
- Progressive multifocal leukoencephalopathy - a rare but serious disease
- Thyroxine (Eutroxsig and Oroxine) and fractures
- Oral bowel cleansing products - serious electrolyte disturbances
- Ondansetron and QTc interval prolongation - dosing change
- Domperidone (Motilium) - serious ventricular arrhythmias and sudden cardiac death
- Cardiovascular safety risk with fingolimod (Gilenya) - updates to the Product Information
- Disposal of unwanted medicines
- Changes to over-the-counter cough and cold medicines for children